Business Segments Novo Nordisk A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 09:50:00 12/01/2026 pm IST			5-day change	1st Jan Change
379.10 ^DKK	-0.62%		+9.33%	+16.56%

01:51am	Novo Nordisk sees oral pills capturing over third of GLP-1 market by 2030	RE
01:33am	Novo EVP for Product and Portfolio Strategy Ludovic Helfgott: Market for Oral Weight-Loss Drugs Could Be One-Third Plus of Overall Market by Turn of Decade	RE

See more © MarketScreener.com

See more © MarketScreener.com

Breakdown by Business Segment (DKK)

Fiscal Period: December	2020	2021	2022	2023	2024
Pharmaceutical Products
Diabetes and Obesity Care	11TCr	12TCr	16TCr	22TCr	27TCr
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
D&A	462.4Cr	489.5Cr	570.1Cr	819.5Cr	710.4Cr
Operating Income	4.37TCr	4.95TCr	6.74TCr	9.96TCr	13TCr
Rare Disease	1.89TCr	1.92TCr	2.05TCr	1.72TCr	1.86TCr
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
D&A	112.9Cr	113Cr	166.1Cr	121.8Cr	144.1Cr
Operating Income	1.04TCr	910.6Cr	741.4Cr	295.1Cr	62Cr
Total Assets	-	-	-	-	-
Total Assets	-	-	-	-	-

Geographical breakdown of sales (DKK)

Fiscal Period: December	2020	2021	2022	2023	2024
United States of America (USA)	5.78TCr	6.3TCr	8.47TCr	13TCr	17TCr
Total Assets	-	-	-	-	5.71TCr
CAPEX	-	-	-	-	-
Total Assets	-	-	-	-	18TCr
EMEA	3.43TCr	3.77TCr	4.42TCr	5.09TCr	6.04TCr
Rest of the World	1.74TCr	1.98TCr	2.54TCr	2.81TCr	3.33TCr
Region China	1.41TCr	1.6TCr	1.62TCr	1.67TCr	1.85TCr
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
North America (Excl. US)	329.3Cr	425.4Cr	645.1Cr	909.5Cr	1.08TCr
Total Assets	-	-	-	-	-
Africa, Asia, Middle East and Oceania (AAMEO)	-	-	-	-	-
Total Assets	-	-	-	-	-
Latin America	-	-	-	-	-
Total Assets	-	-	-	-	-
Pacific	-	-	-	-	-
Total Assets	-	-	-	-	-
Japan & Korea	-	-	-	-	-
Total Assets	-	-	-	-	-
North America	-	-	-	-	-
Total Assets	-	-	-	-	-
Europe	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
International Operations	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-